JPMorgan U.S. Tech Leaders ETF (NASDAQ:JTEK) Hits New 12-Month High – Here’s What Happened

JPMorgan U.S. Tech Leaders ETF (NASDAQ:JTEK) shares reached a new 52-week high on Tuesday . The stock traded as high as $76.00 and last traded at $75.92, with a volume of 4111 shares. The stock had previously closed at $75.42.

JPMorgan U.S. Tech Leaders ETF Price Performance

The company’s fifty day simple moving average is $69.24 and its two-hundred day simple moving average is $67.20. The stock has a market cap of $768.90 million, a price-to-earnings ratio of 47.95 and a beta of 1.82.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of JTEK. Ignite Planners LLC acquired a new position in JPMorgan U.S. Tech Leaders ETF during the second quarter worth $376,000. MBL Wealth LLC bought a new stake in shares of JPMorgan U.S. Tech Leaders ETF in the 2nd quarter worth $2,431,000. Bank of New York Mellon Corp bought a new stake in shares of JPMorgan U.S. Tech Leaders ETF in the 2nd quarter worth $265,000. Commonwealth Equity Services LLC grew its stake in shares of JPMorgan U.S. Tech Leaders ETF by 1,584.3% in the 2nd quarter. Commonwealth Equity Services LLC now owns 81,754 shares of the company’s stock worth $5,661,000 after acquiring an additional 76,900 shares in the last quarter. Finally, Private Wealth Partners LLC grew its stake in shares of JPMorgan U.S. Tech Leaders ETF by 125.1% in the 2nd quarter. Private Wealth Partners LLC now owns 41,075 shares of the company’s stock worth $2,844,000 after acquiring an additional 22,825 shares in the last quarter.

JPMorgan U.S. Tech Leaders ETF Company Profile

The JPMorgan U.S. Tech Leaders ETF JPMorgan U.S. Tech Leaders ETF (JTEK) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that identifies US equities that are perceived as leaders in technology and technology-enabled industries such as engineering & construction, entertainment, biotechnology, pharmaceuticals, REITs, and energy-alternate sources.